About Index Trending news
Analyze
Pricing
Achillion Pharmaceuticals

Achillion Pharmaceuticals

Achillion Pharmaceuticals

An innovative pharmaceutical company dedicated to meeting the needs of patients with HCV & ultra-rare diseases. Disclaimer on our site

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
$50,100,000
Employees

Unknown size

The Motley Fool

Why Achillion Pharmaceuticals Is Down Big in 2016

The Motley Fool

Why Achillion Pharmaceuticals Jumped 10% in May

The Motley Fool

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Stock markets Health
The Motley Fool

Why Achillion Pharmaceuticals Shot 30% Higher in November --

Health Earnings Stock markets
The Motley Fool

Why Achillion Pharmaceuticals Shares Soared in October --

Stock markets Health
The Motley Fool

Why Achillion Pharmaceuticals Shares Are Roaring Higher Today --

Stock markets Health